Trend in the use of antidepressant pharmacotherapy and diagnosis of depression in the US: An assessment of office-based visits 1990 to 1998

CNS Drugs

Volumn 14, Issue 6, 2000, Pages 473-481

  Skaer, T L ^a,b,c   Sclar, D A ^a,c,d   Robison, L M ^a   Galin, R S ^a,b,e  

^a WASHINGTON STATE UNIVERSITY   (United States)

^b Pullman Memorial Hospital   (United States)

^c WASHINGTON STATE UNIVERSITY   (United States)

^d Washington Institute for Mental Illness Research and Training   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT;

ARTICLE; DEPRESSION; DRUG USE; HEALTH CARE UTILIZATION; HUMAN; PATIENT ATTITUDE; PRIORITY JOURNAL; PSYCHIATRIC DIAGNOSIS; PSYCHOPHARMACOTHERAPY; UNITED STATES;

EID: 0034518311     PISSN: 11727047     EISSN: None     Source Type: Journal    
DOI: 10.2165/00023210-200014060-00005     Document Type: Article

References (64)

1. Service utilization and social morbidity associated with depressive symptoms in the community
2. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States: Results of the National Comorbidity Survey
3. Recent progress in the epidemiology of major depression
4. The undertreatment of depression
5. The National Depressive and Manic-Depressive Association consensus statement on the undertreatment of depression
6. Diagnosing major depression in the elderly: Evidence for response bias in standardized diagnostic interviews?
7. Evolutionary trends in the pharmacotherapeutic management of depression
8. Changing patterns of antidepressant use and costs in a health maintenance organization
9. Pharmacokinetics of the newer antidepressants: Clinical relevance
10. Antidepressant pharmacotherapy: Economic outcomes in a health maintenance organization
11. Economic valuation of amitriptyline, desipramine, nortriptyline, and sertraline in the management of patients with depression
12. Economic outcomes with antidepressant pharmacotherapy: A retrospective intent-to-treat analysis
13. Tricyclic antidepressant and selective serotonin reuptake inhibitors antidepressant selection and health care costs in the naturalistic setting: A multivariate analysis
14. Antidepressant selection and use and healthcare expenditures: An empirical approach
15. Initial antidepressant choice in primary care: Effectiveness and cost of fluoxetine vs tricyclic antidepressants
16. The treatment of depression: Prescribing practices of primary care physicians and psychiatrists
17. Trends in the prescription of antidepressants by office-based psychiatrists
18. Trends in the prescribing of antidepressant pharmacotherapy: Office-based visits 1990-1995
19. 1990 summary: National Ambulatory Medical Care survey, United States
20. National Ambulatory Medical Care survey, 1991 summary. National Center for Health Statistics
21. National Ambulatory Medical Care survey, 1992 summary
22. National Ambulatory Medical Care survey, 1993 summary
23. National Ambulatory Medical Care survey, 1994 summary
24. National Ambulatory Medical Care survey, 1995 summary
25. National Ambulatory Medical Care survey, 1996 summary
26. National Ambulatory Medical Care survey, 1997 summary
27. National Ambulatory Medical Care survey, 1998 summary
28. Sampling design, sampling variance, and estimation procedures for the National Ambulatory Medical Care survey. National Center for Health Statistics
29. Statistical export and tabulation system 1.22a: Users reference manual
30. Economic appraisal of citalopram in the management of single-episode depression
31. Anxiety disorders in the United States 1990-1997: Trend in complaint, diagnosis, use of pharmacotherapy, and diagnosis of comorbid depression
32. Psychiatric co-morbidity and pharmacologic treatment patterns among patients presenting with insomnia: An assessment of national office-based encounters 1995-1996
33. Serotonin reuptake inhibitors for the treatment of premenstrual dysphoria
34. Ethnicity and the prescribing of antidepressant pharmacotherapy: 1992-1995
35. A study of the relationship between patients' attitudes and doctors' prescribing
36. Uncomfortable prescribing decisions: A critical incident study
37. Decision making and prescribing patterns: A literature review
38. Factors which influence the decision whether or not to prescribe: The dilemma facing general practitioners
39. Use of health care for the treatment of mental problems among racial/ethnic subpopulations
40. The demand for healthcare among racial/ethnic subpopulations
41. Patient-physician racial concordance and the perceived quality and use of health care
42. The influence of patients' hopes of receiving a prescription on doctors' perceptions and the decision to prescribe: A questionnaire survey
43. Are patients more satisfied when they receive a prescription? The effect of patient expectations in general practice
44. Prescribing behavior in clinical practice: Patients' expectations and doctors' perceptions of patients' expectations: A questionnaire study
45. Influence of patients' expectations on antibiotic management of acute lower respiratory tract illness in general practice: Questionnaire study
46. Contemporary use of antibiotics in 1089 adults presenting with acute lower respiratory tract illness in general practice in the U.K.: Implications for developing management guidelines
47. Patients' demands for prescriptions in primary care
48. Patient demand for prescriptions: A view from the other side
49. Prescribing and referral in general practice: A study of patients' expectations and doctors' actions
50. Primary care physicians' medical decision making for late-life depression
51. What factors influence the prescribing of antidepressant pharmacotherapy? An assessment of national office-based encounters
52. Gender and psychotropic drug use
53. Gender differences in depression in primary care
54. Racial variation in antidepressant treatment in a Medicaid population
55. Antidepressant prescribing patterns: A comparison of blacks and whites in a Medicaid population
56. Pressure to prescribe
57. Caring for depression in America: Lessons learned from early findings of the medical outcomes study
58. Mental health service utilization by African Americans and whites: The Baltimore Epidemiologic Catchment Follow-Up
59. Effectiveness of treatments for major depression in primary medical care practice: A post hoc analysis of outcomes for African American and white patients
60. Stigmatisation of people with mental illness
61. Recognition and treatment of depression in primary care settings in six different countries: A retrospective file analysis by the WHO